National Essential Medicines Lists
Cross-source consensus on National Essential Medicines Lists from 1 sources and 5 claims.
1 sources · 5 claims
How it works
Risks & contraindications
Comparisons
Highlighted claims
- Pakistan included all 67 WHO-listed anticancer medicines in its NEML, while Afghanistan included none. — Determinants of access to anticancer medicines in South Asia: a multimethod study
- Inclusion of WHO-listed anticancer medicines in South Asian NEMLs varied widely across the eight countries. — Determinants of access to anticancer medicines in South Asia: a multimethod study
- NEML inclusion signals national policy commitment and can influence procurement, reimbursement, importation, pricing, and local production. — Determinants of access to anticancer medicines in South Asia: a multimethod study
- Financial limitations and weak infrastructure constrained alignment between national lists and the WHO EML. — Determinants of access to anticancer medicines in South Asia: a multimethod study
- Countries sometimes prioritized local cancer patterns instead of directly adopting WHO EML recommendations. — Determinants of access to anticancer medicines in South Asia: a multimethod study